Kyle Otteson, OD
Optometrist · Bismarck, NDNPI 1679907307
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $694 of the $934 with a category attached, or 74.3%. 8 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 34.9% of the total. Reporting peaked in 2024 at $263 and has fallen 74.8% since, to $66 in 2025.
Across 21 payments — averaging $44.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$326
- The Walman Optical Company$240
- Alcon$177
- Glaukos Corporation$83
- Coopervision Inc.$58
- Dompe US, Inc.$20
- plus $29 from 2 others
What the payments were for
- Food & beverage$69474%
- Gifts$24026%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 6 | $326 |
| The Walman Optical Company | 1 | $240 |
| Alcon | 6 | $177 |
| Glaukos Corporation | 3 | $83 |
| Coopervision Inc. | 2 | $58 |
| Dompe US, Inc. | 1 | $20 |
| Aerie Pharmaceuticals, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
How this compares
$934 in reported general payments places this provider in the 75th percentile of 179 optometrist providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 38 | $457 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 34 | $448 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Bismarck
- Paul BallietBismarck$2K
- Danelle MochBismarck$1K
- Steven TowleBismarck$1K
- Thomas HanstedBismarck$1K
- Brian BeattieBismarck$926
- Wesley SchwartzBismarck$752
- Krista HeilBismarck$644
- Timothy TelloBismarck$639
- Kellen PathroffBismarck$633
- Brooke MesserWest Fargo$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.